20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Liquidia Technologies Inc (LQDA) operates in the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry and is headquartered in Morrisville, United States with about 216 employees. Its market capitalization is roughly $6 billion. In the fiscal year ended 2025-12-31, LQDA reported $158M in revenue and ($69M) in net income.
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States.
Interactive charts & full statements → Open the LQDA valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $451M | $158M | $14M | $17M | $16M | $13M | $1M | $8M | $3M | $7M | $13M |
| Gross Profit | $417M | $145M | $8M | $15M | $13M | $10M | $1M | $7M | $3M | $7M | $12M |
| Gross Margin % | 92.5% | 91.6% | 58.0% | 83.5% | 82.1% | 76.5% | 67.9% | 90.0% | 95.5% | 95.6% | 93.0% |
| Operating Income (EBIT) | $170M | ($51M) | ($121M) | ($73M) | ($39M) | ($34M) | ($59M) | ($47M) | ($35M) | ($28M) | ($16M) |
| Operating Margin % | 37.7% | -32.5% | -866.6% | -419.6% | -243.3% | -263.0% | -7989.0% | -580.1% | -1288.1% | -386.2% | -120.0% |
| Net Income | $139M | ($69M) | ($130M) | ($79M) | ($41M) | ($35M) | ($60M) | ($48M) | ($53M) | ($29M) | ($16M) |
| Net Margin % | 30.8% | -43.5% | -931.6% | -448.9% | -257.4% | -269.0% | -8080.1% | -589.5% | -1962.9% | -401.7% | -120.6% |
| EBITDA | — | ($43M) | ($116M) | ($70M) | ($35M) | ($28M) | ($56M) | ($43M) | ($33M) | ($15M) | ($15M) |
| Earnings Per Share (EPS) | $1.37 | $-0.80 | $-1.66 | $-1.21 | $-0.67 | $-0.70 | $-1.76 | $-2.57 | $-7.42 | $-3.40 | $-3.13 |
| Shares Outstanding (M) | — | 86M | 79M | 65M | 61M | 50M | 34M | 18M | 7M | 9M | 5M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $172M | $133M | $92M | $54M | $9M | $3M | $3M | $4M | $4M |
| Gross Profit | $160M | $121M | $85M | $51M | $8M | $2M | $2M | $3M | $2M |
| Gross Margin % | 93.0% | 90.9% | 92.3% | 94.2% | 85.4% | 51.4% | 53.6% | 64.8% | 59.2% |
| Operating Income (EBIT) | $86M | $62M | $20M | $2M | ($38M) | ($35M) | ($36M) | ($29M) | ($27M) |
| Operating Margin % | 50.0% | 46.3% | 21.5% | 3.2% | -424.4% | -1135.4% | -1237.8% | -656.2% | -743.3% |
| Net Income | $75M | $53M | $15M | ($4M) | ($42M) | ($38M) | ($38M) | ($23M) | ($28M) |
| Net Margin % | 43.6% | 39.8% | 15.8% | -6.5% | -470.5% | -1229.7% | -1315.4% | -520.6% | -763.6% |
| EBITDA | — | $64M | $22M | $4M | ($36M) | ($33M) | ($33M) | ($20M) | ($25M) |
| Earnings Per Share (EPS) | $0.74 | $0.52 | $0.15 | $-0.04 | $-0.49 | $-0.45 | $-0.45 | $-0.30 | — |
| Shares Outstanding (M) | — | 101M | 100M | 86M | 86M | 85M | 85M | 78M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $78M | ($36M) | ($93M) | ($42M) | ($29M) | ($34M) | ($54M) | ($48M) | ($32M) | ($24M) | ($14M) |
| Capital Expenditures (CapEx) | $18M | $4M | $5M | $1M | $1M | $0M | $1M | $2M | $1M | $3M | $3M |
| Free Cash Flow (FCF) | $60M | ($40M) | ($98M) | ($43M) | ($29M) | ($34M) | ($55M) | ($50M) | ($33M) | ($27M) | ($17M) |
| FCF Margin % | 13.3% | -25.3% | -702.9% | -245.0% | -183.1% | -265.6% | -7422.2% | -621.1% | -1208.0% | -369.7% | -127.4% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $80M | ($36M) | $44M | ($10M) | ($39M) | ($31M) | ($21M) | ($25M) |
| Capital Expenditures (CapEx) | $11M | $4M | $2M | $1M | $1M | $0M | $5M | $2M |
| Free Cash Flow (FCF) | $69M | ($40M) | $42M | ($11M) | ($41M) | ($31M) | ($26M) | ($27M) |
| FCF Margin % | — | -30.1% | 45.9% | -19.7% | -458.7% | -993.9% | -877.7% | -603.2% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $522M | $328M | $230M | $118M | $129M | $94M | $100M | $69M | $49M | $15M | $8M |
| Cash & Cash Equivalents | $284M | $191M | $176M | $84M | $93M | $57M | $65M | $56M | $40M | $3M | $1M |
| Total Liabilities | $327M | $283M | $153M | $71M | $39M | $28M | $28M | $34M | $31M | $49M | $27M |
| Total Debt (Short + Long-Term) | $55M | $192M | $116M | $47M | $21M | $11M | $12M | $18M | $12M | $22M | $8M |
| Total Shareholders' Equity | $195M | $45M | $77M | $47M | $90M | $65M | $71M | $35M | $19M | ($34M) | ($18M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LQDA viewer.
About TickerBase · Data methodology & sources · Privacy · Terms